To evaluate the clinical utility of the CAMUNI-MATISS 20-year risk score, recently validated for the Italian population, as additional screening tool for individuals at "low" (ESC-SCORE Project predicted 10-year risk ≤ 1%; no preventive action), "intermediate" (ESC-SCORE 1-4%; lifestyle modification/statin treatment) and "high" risk (ESC-SCORE≥ 4% or diabetes; statin treatment) according to the Italian regulation.

OS 06-07 COMBINING SHORT- AND LONG-TERM RISK SCORES IN PRIMARY PREVENTION OF MAJOR CARDIOVASCULAR DISEASE EVENTS IN LOW INCIDENCE POPULATIONS: AN ASSESSMENT OF CLINICAL UTILITY

VERONESI, GIOVANNI;GIANFAGNA, FRANCESCO;FERRARIO, MARCO MARIO ANGELO
2016-01-01

Abstract

To evaluate the clinical utility of the CAMUNI-MATISS 20-year risk score, recently validated for the Italian population, as additional screening tool for individuals at "low" (ESC-SCORE Project predicted 10-year risk ≤ 1%; no preventive action), "intermediate" (ESC-SCORE 1-4%; lifestyle modification/statin treatment) and "high" risk (ESC-SCORE≥ 4% or diabetes; statin treatment) according to the Italian regulation.
2016
Veronesi, Giovanni; Giampaoli, Simona; Gianfagna, Francesco; Palmieri, Luigi; Vanuzzo, Diego; Grassi, Guido; Cesana, Giancarlo; Ferrario, MARCO MARIO ...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2059391
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact